Prosecution Insights
Last updated: August 18, 2026

Examiner: MCGRATH, ERIN E

Tech Center 4100 • Art Units: 3742 3761 3771 3796 4100

This examiner grants 60% of resolved cases

Performance Statistics

60.0%
Allow Rate
At TC average
480
Total Applications
+29.6%
Interview Lift
1300
Avg Prosecution Days
Based on 438 resolved cases, 2023–2026

Rejection Statute Breakdown

0.6%
§101 Eligibility
15.3%
§102 Novelty
48.8%
§103 Obviousness
33.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17477990 DEVICES, SYSTEMS, AND METHODS FOR LOCATING A BODY LUMEN Non-Final OA Boston Scientific Scimed, Inc.
18541175 MEDICAL SYSTEMS, DEVICES, AND RELATED METHODS Non-Final OA BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED
18850363 System And Methods For Providing Tamponade And Suction-Based Treatment To A Uterus Non-Final OA Stryker Corporation
18430556 BIOMETRIC ANIMAL IDENTIFICATION SYSTEM Non-Final OA RapID Lab, Inc.
17785494 SYSTEM AND METHOD FOR CONTROLLING AN ULTRASONIC SURGICAL SYSTEM Final Rejection Covidien LP
18839526 SYSTEM AND METHOD FOR ALIGNING MOVEMENT DIRECTION OF INTERVENTIONAL DEVICE IN IMAGE AND CONTROL DIRECTION OF COMMANDS ENTERED BY USER Final Rejection KONINKLIJKE PHILIPS N.V.
18828650 ULTRASONIC TRANSDUCER, ULTRASONIC TREATMENT TOOL AND METHOD OF PRODUCING ULTRASONIC TRANSDUCER Final Rejection Olympus Medical Systems Corp.
18432767 OPHTHALMOSCOPIC CONTACT LENSES Final Rejection Alcon Inc.
18799764 VIBRATIONAL AND ROTATIONAL CALCULUS BASKET Final Rejection GYRUS ACMI, INC D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
18899278 MEDICAL DEVICE Non-Final OA TERUMO KABUSHIKI KAISHA
19214411 DEVICES AND METHODS FOR COSMETIC SKIN RESURFACING Non-Final OA Cytrellis Biosystems, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month